Scientech Research LLC’s Recursion Pharmaceuticals RXRX Stock Holding History

Scientech Research LLC’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$82.6K	Buy	26,902 +10,445	+63%	+$40.4K	0.07%	361
2025 Q4	$67.3K	Buy	16,457 +3,031	+23%	+$15K	0.04%	434
2025 Q3	$65.5K	Sell	13,426 -115,637	-90%	-$607K	0.02%	508
2025 Q2	$653K	Buy	+129,063	New	+$634K	0.16%	264
2024 Q4	–	Sell	-88,103	Closed	-$581K	–	820
2024 Q3	$581K	Sell	88,103 -52,192	-37%	-$374K	0.12%	343
2024 Q2	$1.05M	Buy	+140,295	New	+$1.22M	0.22%	171

Other funds holding RXRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Scientech Research LLC's RXRX Position: Q1 2026 in Review

Scientech Research LLC increased its Recursion Pharmaceuticals (RXRX) stake by 63% in Q1 2026, buying an estimated $40.4K and bringing the position to 26,902 shares worth $82.6K. The position accounts for 0.07% of the portfolio, ranked #361.

Scientech Research LLC first reported a position in RXRX in Q2 2024 and has held it in 6 quarters since. The position peaked at $1.05M in Q2 2024. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

Scientech Research LLC held 26,902 shares of Recursion Pharmaceuticals worth $82.6K as of Q1 2026.
Scientech Research LLC bought 10,445 Recursion Pharmaceuticals shares in Q1 2026, an estimated $40.4K.
Recursion Pharmaceuticals made up 0.07% of Scientech Research LLC's portfolio in Q1 2026, its #361 holding.
Scientech Research LLC first reported a position in Recursion Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
Scientech Research LLC's Recursion Pharmaceuticals position peaked at $1.05M in Q2 2024.
334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.